Wells Fargo
AKRO

Wells Fargo’s Akero Therapeutics AKRO Stock Holding History

Wells Fargo’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-42,500
Closed -$1.45M – 7441
2022
Q3 		$1.45M Buy
+42,500
New +$650K ﹤0.01% 2983

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's AKRO Position: Q4 2025 in Review

Wells Fargo sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 43,702 shares — an estimated $2.07M sold.

Wells Fargo first reported a position in AKRO in Q3 2019 and held it in 25 quarters. The position peaked at $2.31M in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Wells Fargo reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Wells Fargo sold 43,702 Akero Therapeutics shares in Q4 2025, an estimated $2.07M.
  • Wells Fargo first reported a position in Akero Therapeutics in Q3 2019 and held it in 25 quarters.
  • Wells Fargo's Akero Therapeutics position peaked at $2.31M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.